Related Experiment Video

Updated: Jun 17, 2026

Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4
12:09

Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4

Published on: December 31, 2013

Novel role for the transient receptor potential channel TRPM2 in prostate cancer cell proliferation

X Zeng1, S C Sikka, L Huang

  • 1Department of Urology, Tulane University Health Sciences Center, New Orleans, LA, USA.

Prostate Cancer and Prostatic Diseases
|December 24, 2009
PubMed

Insights

Transient Receptor Potential Melastatin 2 (TRPM2) protein drives prostate cancer cell growth. Inhibiting TRPM2 selectively halts cancer cell proliferation, suggesting it as a potential therapeutic target.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Prostate cancer remains a leading cause of cancer-related deaths worldwide.
  • The Transient Receptor Potential (TRP) protein super-family plays diverse cellular roles.
  • Understanding novel regulators of prostate cancer cell proliferation is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of TRPM2, a TRP channel protein, in prostate cancer cell proliferation.
  • To determine if TRPM2 is a potential therapeutic target for prostate cancer treatment.

Main Methods:

  • Utilized small interfering RNA (siRNA) to selectively knock down TRPM2 expression in prostate cancer cell lines (PC-3, DU-145) and benign prostate cells (BPH-1).
  • Assessed the impact of TRPM2 knockdown on cell proliferation using cell growth assays.
  • Examined the subcellular localization of TRPM2 protein in both cancerous and non-cancerous prostate cells via microscopy.
  • Investigated the effect of TRPM2 on nuclear ADP-ribosylation and its independence from poly(ADP-ribose) polymerases (PARPs).

Main Results:

  • Selective knockdown of TRPM2 significantly inhibited prostate cancer cell proliferation while sparing non-cancerous cells.
  • TRPM2 exhibited distinct subcellular localization patterns: homogenous near plasma membrane/cytoplasm in benign cells versus nuclear clusters in cancer cells.
  • TRPM2 was found to inhibit nuclear ADP-ribosylation in prostate cancer cells.
  • The anti-proliferative effect of TRPM2 knockdown was independent of PARP activity.

Conclusions:

  • TRPM2 is essential for the proliferation of prostate cancer cells.
  • TRPM2's unique nuclear localization and function in prostate cancer suggest it is a promising target for selective prostate cancer therapies.
  • Targeting TRPM2 offers a potential strategy for developing novel, selective treatments for prostate cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mechanically-gated Ion Channels01:12

Mechanically-gated Ion Channels

Mechanically-gated ion channels are proteins found in eukaryotic and prokaryotic cell membranes that open in response to mechanical stress. Tension, compression, swelling, and shear stress can alter the conformation of the protein, opening a transmembrane channel that allows the passage of ions for signal transmission. In eukaryotes, mechanically-gated channels are distributed in several regions like the neurons, lungs, skin, bladder, and heart, where they play critical roles in numerous...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...